Martin-Orozco [60] found that Th17 cells can promote the recruitment of T cells to tumor sites, participate in antitumor immunity, and activate the production of CCL2 and CCL20 by secreting IL-17-activated border cells. The gene discussed is IL17A; the disease is neoplasm.